BDBM784312 US20250340529, Compound 514

SMILES Cc1c(-c2ccc3c(c2)OCC(=O)N3CCN2C[C@H](O)C[C@H]2C(=O)O)cccc1-c1cccc(-c2ccc3c(c2)OCC(=O)N3CCN2C[C@H](O)C[C@H]2C(=O)O)c1C

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 784312   

TargetProgrammed cell death 1 ligand/protein 1(Human)
Ascletis Bioscience Co.

US Patent
LigandPNGBDBM784312(US20250340529, Compound 514)
Affinity DataIC50: 4.46nMAssay Description:Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent